Regentis Biomaterials Company
Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.
Technology:
Bioengineering, Tissue Engineering
Industry:
Private, Regenerative Medicine
Headquarters:
Or Akiva, Hefa, Israel
Founded Date:
2004-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
8
Total Funding:
36077937
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-01-01
Last Funding Type:
Grant
Register and Claim Ownership